Disease, Disability, and Injury Prevention and Control, 15610 [2015-06650]

Download as PDF 15610 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Prevention and the Agency for Toxic Substances and Disease Registry. Centers for Disease Control and Prevention Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Cooperative Research Agreements to the World Trade Center Health Program (U01) PAR 12–126, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: mstockstill on DSK4VPTVN1PROD with NOTICES 8:00 a.m.–5:00 p.m., April 14, 2015 (Closed) 8:00 a.m.–12:00 p.m., April 15, 2015 (Closed) Place: Atlanta Marriott Century Center, 2000 Century Boulevard NE., Atlanta, Georgia 30345, Telephone: (404) 325–0000. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Cooperative Research Agreements Related to the World Trade Center Health Program (U01) PAR 12–126.’’ Contact Person for More Information: Nina Turner, Ph.D., Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, Morgantown, West Virginia 26505, Telephone: (304) 285–5975. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015–06650 Filed 3–23–15; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 01:09 Mar 24, 2015 Jkt 235001 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcements (FOA) GH11–002, Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH); FOA GH12–004M, Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS); FOA GH12–005, Conducting Public Health Research in China; and FOA GH14–002, Addressing Emerging Infectious Diseases in Bangladesh. Time and Date: 8:30 a.m.–1:00 p.m., EST, April 15, 2015 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to FOA GH11–002, Conducting Public Health Research in Thailand by the Ministry of Public Health (MOPH); FOA GH12–004, Conducting Public Health Research in South Africa by the National Health Laboratory Service (NHLS); FOA GH12–005, Conducting Public Health Research in China; and FOA GH14–002, Addressing Emerging Infectious Diseases in Bangladesh. Contact Person for More Information: Hylan Shoob, Scientific Review Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 Clifton Road NE., Mailstop D–69, Atlanta, Georgia 30033, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00063 Fmt 4703 Sfmt 9990 [FR Doc. 2015–06653 Filed 3–23–15; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel Pathobiology of Asthma. Date: April 14, 2015. Time: 1:30 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6705 Rockledge Drive, Room 7180, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Tony L Creazzo, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7180, Bethesda, MD 20892–7924, 301–435– 0725 creazzotl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: March 18, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–06594 Filed 3–23–15; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\24MRN1.SGM 24MRN1

Agencies

[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15610]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06650]



[[Page 15610]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control

    Special Emphasis Panel (SEP): Initial Review
    The meeting announced below concerns Cooperative Research 
Agreements to the World Trade Center Health Program (U01) PAR 12-126, 
initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date:

8:00 a.m.-5:00 p.m., April 14, 2015 (Closed)
8:00 a.m.-12:00 p.m., April 15, 2015 (Closed)

    Place: Atlanta Marriott Century Center, 2000 Century Boulevard NE., 
Atlanta, Georgia 30345, Telephone: (404) 325-0000.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Cooperative Research Agreements Related to the World Trade Center 
Health Program (U01) PAR 12-126.''
    Contact Person for More Information: Nina Turner, Ph.D., Scientific 
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, 
Morgantown, West Virginia 26505, Telephone: (304) 285-5975.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-06650 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.